Primary Site >> Colorectal Cancer
Gene >> ENG
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. PMID: 11121063 |
Ref: Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin. PMID: 11297243 Ref: Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts. PMID: 11848470 |
Ref: CD105 is important for angiogenesis: evidence and potential applications. PMID: 12773481 |
Ref: Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. PMID: 14657950 |
Ref: Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. PMID: 16177881 Ref: [Mechanisms of metastasis and molecular markers of malignant tumor progression. I. Colorectal cancer]. PMID: 17013365 Ref: Effective anti-angiogenic therapy of established tumors in mice by naked anti-human endoglin (CD105) antibody: differences in growth rate and therapeutic response between tumors growing at different sites. PMID: 17016638 Ref: Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. PMID: 17096728 |
Ref: Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice. PMID: 18224682 Ref: A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis. PMID: 18794116 |
Ref: Anti-endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculature. PMID: 19533687 |
Ref: Abnormal expression of Endoglin and its receptor complex (TGF-beta1 and TGF-beta receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa. PMID: 20878063 |
Ref: Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. PMID: 21737454 |
Ref: Genetic polymorphism in a VEGF-independent angiogenesis gene ANGPT1 and overall survival of colorectal cancer patients after surgical resection. PMID: 22496856 Ref: Preoperative serum levels of soluble endoglin for prediction of recurrence in stage III colorectal cancer patients. PMID: 23101269 |
Ref: Comparison of protein immunoprecipitation-multiple reaction monitoring with ELISA for assay of biomarker candidates in plasma. PMID: 24224610 |
Ref: Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings. PMID: 24625025 Ref: Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines. PMID: 25092771 |
Ref: Facilitation of endoglin-targeting cancer therapy by development/utilization of a novel genetically engineered mouse model expressing humanized endoglin (CD105). PMID: 24866768 Ref: Prognostic Significance of Microvessel Density Determining by Endoglin in Stage II Rectal Carcinoma: A Retrospective Analysis. PMID: 26089870 |
Ref: Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis. PMID: 27102733 Ref: Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/beta-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer. PMID: 27127133 Ref: Expression of Endoglin and Vascular Endothelial Growth Factor as Prognostic Markers in Experimental Colorectal Cancer. PMID: 27466499 |
Ref: Targeted sequencing of established and candidate colorectal cancer genes in the Colon Cancer Family Registry Cohort. PMID: 29212164 |